Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter C Harris

Showing results (231-240 of 314) with videos related to

Pageof 32
Sort By:
The Journal of Gene Medicine|February 26, 2024
Global analysis of urinary extracellular vesicle small RNAs in autosomal dominant polycystic kidney diseaseHamad Ali, Md Zubbair Malik, Mohamed Abu-Farha, et al.
European Journal of Human Genetics : EJHG|August 12, 2018
Characterization of three ciliopathy pedigrees expands the phenotype associated with biallelic C2CD3 variantsNicole J Boczek, Katharina Hopp, Lacey Benoit, et al.
Kidney International Reports|November 13, 2024
Opportunities in Primary and Enteric Hyperoxaluria at the Cross-Roads Between the Clinic and LaboratoryBarbara Cellini, Michelle A Baum, Yaacov Frishberg, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 27, 2020
Pansomatostatin Agonist Pasireotide Long-Acting Release for Patients with Autosomal Dominant Polycystic Kidney or Liver Disease with Severe Liver Involvement: A Randomized Clinical TrialMarie C Hogan, Julie A Chamberlin, Lisa E Vaughan, et al.
Kidney International Reports|March 18, 2021
Characteristics of Patients with End-Stage Kidney Disease in ADPKDShehbaz S Shukoor, Lisa E Vaughan, Marie E Edwards, et al.
Clinical Journal of the American Society of Nephrology : CJASN|July 21, 2018
Long-Term Administration of Tolvaptan in Autosomal Dominant Polycystic Kidney DiseaseMarie E Edwards, Fouad T Chebib, Maria V Irazabal, et al.
Current Hypertension Reviews|May 3, 2017
Effect of Statin Therapy on the Progression of Autosomal Dominant Polycystic Kidney Disease. A Secondary Analysis of the HALT PKD TrialsGodela M Brosnahan, Kaleab Z Abebe, Frederic F Rahbari-Oskoui, et al.
Human Genome Variation|December 27, 2016
Digenic mutations of human <i>OCRL</i> paralogs in Dent's disease type 2 associated with Chiari I malformationDaniel Duran, Sheng Chih Jin, Tyrone DeSpenza, et al.
Kidney360|August 15, 2024
Robotic Ultrasound and Novel Collagen Analyses for Polycystic Kidney Disease Research Using MiceCaroline R Sussman, Heather L Holmes, Alison Stiller, et al.
Kidney International Reports|January 10, 2022
<i>PKD1</i> Compared With <i>PK</i> <i>D2</i> Genotype and Cardiac Hospitalizations in the Halt Progression of Polycystic Kidney Disease StudiesCortney Steele, Zhiying You, Berenice Y Gitomer, et al.
Pageof 32

Showing results (231-240 of 314) with videos related to

Sort By:
Pageof 32
The Journal of Gene Medicine|February 26, 2024
Global analysis of urinary extracellular vesicle small RNAs in autosomal dominant polycystic kidney diseaseHamad Ali, Md Zubbair Malik, Mohamed Abu-Farha, et al.
European Journal of Human Genetics : EJHG|August 12, 2018
Characterization of three ciliopathy pedigrees expands the phenotype associated with biallelic C2CD3 variantsNicole J Boczek, Katharina Hopp, Lacey Benoit, et al.
Kidney International Reports|November 13, 2024
Opportunities in Primary and Enteric Hyperoxaluria at the Cross-Roads Between the Clinic and LaboratoryBarbara Cellini, Michelle A Baum, Yaacov Frishberg, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 27, 2020
Pansomatostatin Agonist Pasireotide Long-Acting Release for Patients with Autosomal Dominant Polycystic Kidney or Liver Disease with Severe Liver Involvement: A Randomized Clinical TrialMarie C Hogan, Julie A Chamberlin, Lisa E Vaughan, et al.
Kidney International Reports|March 18, 2021
Characteristics of Patients with End-Stage Kidney Disease in ADPKDShehbaz S Shukoor, Lisa E Vaughan, Marie E Edwards, et al.
Clinical Journal of the American Society of Nephrology : CJASN|July 21, 2018
Long-Term Administration of Tolvaptan in Autosomal Dominant Polycystic Kidney DiseaseMarie E Edwards, Fouad T Chebib, Maria V Irazabal, et al.
Current Hypertension Reviews|May 3, 2017
Effect of Statin Therapy on the Progression of Autosomal Dominant Polycystic Kidney Disease. A Secondary Analysis of the HALT PKD TrialsGodela M Brosnahan, Kaleab Z Abebe, Frederic F Rahbari-Oskoui, et al.
Human Genome Variation|December 27, 2016
Digenic mutations of human <i>OCRL</i> paralogs in Dent's disease type 2 associated with Chiari I malformationDaniel Duran, Sheng Chih Jin, Tyrone DeSpenza, et al.
Kidney360|August 15, 2024
Robotic Ultrasound and Novel Collagen Analyses for Polycystic Kidney Disease Research Using MiceCaroline R Sussman, Heather L Holmes, Alison Stiller, et al.
Kidney International Reports|January 10, 2022
<i>PKD1</i> Compared With <i>PK</i> <i>D2</i> Genotype and Cardiac Hospitalizations in the Halt Progression of Polycystic Kidney Disease StudiesCortney Steele, Zhiying You, Berenice Y Gitomer, et al.
Pageof 32